Drug updated on 10/23/2023

Dosage FormTablet (oral: 2.5 mg, 5 mg, 10 mg, 20 mg)
Drug ClassPhosphodiesterase 5 (PDE5) inhibitor
Ongoing and
Completed Studies


  • For the treatment of erectile dysfunction (ED).
  • For the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
  • For the treatment of ED and the signs and symptoms of BPH (ED/BPH).

Product Monograph / Prescribing Information

Document TitleYearSource
Cialis (tadalafil) Prescribing Information.2023Lilly USA, LLC Indianapolis, IN

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines

Document TitleYearSource
Erectile dysfunction: AUA guideline (2018).2018American Urology Association